Since 1995, the Northwest Clinical Research Center has partnered with the pharmaceutical industry to conduct clinical research trials and is dedicated to providing quality medical treatment and patient safety. Each patient receives psychological assessments and health evaluations by our medical staff. Our specialty is psychiatry and the treatment of mood disorders.
ARIF KHAN, M.D.
Dr. Khan is a Board Certified Psychiatrist and Adjunct Professor of Psychiatry at Duke University School of Medicine. He is the Medical Director and Principal Investigator at NNWCRC. Dr. Khan has been conducting clinical trials in the greater Seattle area since 1984 and founded NWCRC in 1995.
He has been the Principal Investigator in over 250 clinical trials, and published more than 150 scientific papers in leading medical journals. His work on clinical trial design, safety and efficacy is widely recognized and presented at national and international scientific meetings. Dr. Khan has published papers about anxiety in medical and psychiatric journals around the world.
You can view abstracts of his publications by clicking on the links below.
Suicide risk in patients with anxiety disorders: a meta-analysis of the FDA database. Click here
A double-blind, placebo-controlled study of a flexible dose of Venlafaxine ER in adult outpatients with
Generalized Social Anxiety Disorder. Click here
Relapse prevention of panic disorder in adult outpatient responders to treatment with Venlafaxine
Extended Release. Click here
GAYLON KIPP, M.D.
Dr. Kipp is a Board Certified primary care physician and has provided care to patients for over 30 years. He is currently a medical sub-investigator and has contributed to over 65 clinical trials here at NWCRC. When asked about his work, he says, “I enjoy patient contact and knowing that I’m making a difference through research.”